Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): The Small Business Innovation Research (SBIR) 020, “New Laboratory Tests for Tuberculosis and Detection of Drug Resistance” and SRIB 021, “Development of Novel Information System for Remote Tuberculosis Control and Prevention”, 8166 [E7-3102]
Download as PDF
<![CDATA[
8166
Federal Register / Vol. 72, No. 36 / Friday, February 23, 2007 / Notices
uninsured or underinsured populations
even if there is underutilized capacity.
The study will also determine whether
there are factors that affect average
variable costs across facilities such as
the number of procedures performed,
specialization in types of procedures or
other characteristics of the facility.
Results of this study will be used to
better understand the economics of
colorectal cancer screening.
Respondents include medical facility
receptionists, hospital operators, and
office/business managers. The total
estimated cost to respondents is
approximately $72,800 assuming an
hourly wage of $37 for office/business
managers and an hourly wage of $11 for
others during the study period. There
are no costs to the respondents other
than their time. The total estimated
annualized burden hours are 2072.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Receptionist ..........................................................
OPHD nurse manager ..........................................
ASC nurse manager .............................................
Telephone screening survey ................................
SECOST mail survey ...........................................
SECOST mail survey ...........................................
Dated: February 16, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–3099 Filed 2–22–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. E7–3103 Filed 2–22–07; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health: Notice of Charter
Renewal
cprice-sewell on PROD1PC61 with NOTICES
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Centers for Disease Control and
Prevention
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Board
of Scientific Counselors, National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, Department of Health and
Human Services, has been renewed for
a 2-year period through February 3,
2009.
For information, contact Dr. Roger
Rosa, Executive Secretary, Board of
Scientific Counselors, National Institute
for Occupational Safety and Health,
Centers for Disease Control and
Prevention, Department of Health and
Human Services, CDC/Washington
Office, HHH Building, 200
Independence Ave, SW., Room 715H,
MS P12, Washington, DC 20201—
telephone 202/205–7856 or fax 202/
260–4464.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): The Small
Business Innovation Research (SBIR)
020, ‘‘New Laboratory Tests for
Tuberculosis and Detection of Drug
Resistance’’ and SRIB 021,
‘‘Development of Novel Information
System for Remote Tuberculosis
Control and Prevention’’
1 We expect that we will have to make 4,160
screening telephone calls to identify a sample of
1 4,160
1,000
725
15:07 Feb 22, 2007
Jkt 211001
Average
burden per
response
(in hours)
1
1
1
5/60
1
1
response to The Small Business Innovation
Research (SBIR) 020, ‘‘New Laboratory Tests
for Tuberculosis and Detection of Drug
Resistance’’ and SRIB 021, ‘‘Development of
Novel Information System for Remote
Tuberculosis Control and Prevention.’’
Contact Person for More Information: J.
Felix Rogers, PhD, M.P.H., Scientific Review
Administrator, Coordinating Center for
Infectious Diseases, National Center for
Immunization and Respiratory Diseases,
Office of the Director, CDC, 1600 Clifton
Road NE., Mailstop E05, Atlanta, GA 30333,
Telephone 404.639.6101.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
1,250 HOPDs and 906 ASCs that are eligible for
inclusion in the study.
VerDate Aug<31>2005
Number of
responses
per respondent
Dated: February 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–3102 Filed 2–22–07; 8:45 am]
BILLING CODE 4163–18–P
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Times and Dates: 1 p.m.–2 p.m., March 30,
2007 (Closed). 2 p.m.–4 p.m., March 30, 2007
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
The Health Department Subcommittee
of the Board of Scientific Counselors
(BSC), Centers for Disease Control and
Prevention (CDC), National Center for
Environmental Health (NCEH)/Agency
for Toxic Substances and Disease
Registry (ATSDR): Teleconference
Meeting.
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 72, Number 36 (Friday, February 23, 2007)]
[Notices]
[Page 8166]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3102]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panels (SEP): The Small Business Innovation Research (SBIR)
020, ``New Laboratory Tests for Tuberculosis and Detection of Drug
Resistance'' and SRIB 021, ``Development of Novel Information System
for Remote Tuberculosis Control and Prevention''
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Times and Dates: 1 p.m.-2 p.m., March 30, 2007 (Closed). 2 p.m.-
4 p.m., March 30, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
The Small Business Innovation Research (SBIR) 020, ``New Laboratory
Tests for Tuberculosis and Detection of Drug Resistance'' and SRIB
021, ``Development of Novel Information System for Remote
Tuberculosis Control and Prevention.''
Contact Person for More Information: J. Felix Rogers, PhD,
M.P.H., Scientific Review Administrator, Coordinating Center for
Infectious Diseases, National Center for Immunization and
Respiratory Diseases, Office of the Director, CDC, 1600 Clifton Road
NE., Mailstop E05, Atlanta, GA 30333, Telephone 404.639.6101.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: February 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-3102 Filed 2-22-07; 8:45 am]
BILLING CODE 4163-18-P
